Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 TrialAlan K. Burnett, Donald Milligan, Nigel H. Russell et al.|Journal of Clinical Oncology|2013Cited by 415
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in ChildrenVéronique Minard‐Colin, Thomas G. Gross, Andrew Wotherspoon et al.|New England Journal of Medicine|2020Cited by 308
Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12Christine J. Harrison, Brenda Gibson, Robert K. Hills et al.|Journal of Clinical Oncology|2010Cited by 305
Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 TrialAlan K. Burnett, Keith Wheatley, Robert K. Hills et al.|Journal of Clinical Oncology|2009Cited by 229
Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trialBrenda Gibson, David Webb, Andrew Howman et al.|British Journal of Haematology|2011Cited by 205